Patents by Inventor Roel Jos M. Mertens

Roel Jos M. Mertens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20230302024
    Abstract: This invention relates to solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
    Type: Application
    Filed: May 5, 2023
    Publication date: September 28, 2023
    Inventors: Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Eugeen Maria Jozef JANS, Roel Jos M. MERTENS, Geert VAN DER AVOORT
  • Darunavir combination formulations
    Patent number: 11654150
    Abstract: This invention relate to solid oral dosage forms of tire HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulation thereof.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: May 23, 2023
    Assignee: Janssen Sciences Ireland UC
    Inventors: Urbain Alfons C. Delaet, Philip Erna H. Heyns, Eugeen Maria Jozef Jans, Roel Jos M. Mertens, Geert Van Der Avoort
  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20200093840
    Abstract: This invention relate to solid oral dosage forms of tire HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulation thereof.
    Type: Application
    Filed: November 27, 2019
    Publication date: March 26, 2020
    Inventors: Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Eugeen Maria Jozef JANS, Roel Jos M. MERTENS, Geert VAN DER AVOORT
  • Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
    Patent number: 9161917
    Abstract: Process for preparing a powder comprising the steps of providing at least one first component in liquid form at ambient temperature, providing at least one second component having a melting point or melting range in the range from above ambient temperature to below the degradation temperature of said first component, forming a homogenous liquid mixture comprising the at least one first component and the at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature in the range from above the melting point or melting range of the second component and below the degradation temperature of the first component, transferring the liquid mixture to at least one spray congealing unit, spray congealing the mixture, and isolating the powder obtained upon spray congealing.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: October 20, 2015
    Assignee: GRÜNENTHAL GMBH
    Inventors: Anne Faure, Jody Firim Marceline Voorspoels, Roel Jos M. Mertens, Filip René Irena Kiekens
  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20140142070
    Abstract: This invention relates to solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
    Type: Application
    Filed: July 6, 2012
    Publication date: May 22, 2014
    Applicant: Janssen R&D Ireland
    Inventors: Urbain Alfons C Delaet, Philip Erna H. Heyns, Eugeen Maria Jozef Jans, Roel Jos M. Mertens, Geert Van Der Avoort
  • PROCESS FOR THE PREPARATION OF A SOLID DOSAGE FORM, IN PARTICULAR A TABLET, FOR PHARMACEUTICAL USE AND PROCESS FOR THE PREPARATION OF A PRECURSOR FOR A SOLID DOSAGE FORM, IN PARTICULAR A TABLET
    Publication number: 20110082214
    Abstract: Process for preparing a powder comprising the steps of providing at least one first component in liquid form at ambient temperature, providing at least one second component having a melting point or melting range in the range from above ambient temperature to below the degradation temperature of said first component, forming a homogenous liquid mixture comprising the at least one first component and the at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature in the range from above the melting point or melting range of the second component and below the degradation temperature of the first component, transferring the liquid mixture to at least one spray congealing unit, spray congealing the mixture, and isolating the powder obtained upon spray congealing.
    Type: Application
    Filed: November 1, 2010
    Publication date: April 7, 2011
    Applicant: GRUENTHAL GMBH
    Inventors: Anne Faure, Jody Firim Marceline Voorspoels, Roel Jos M. Mertens, Filip René Irena Kiekens